Reforming Industry Funded Regulators
- Eleos Fry
- Jul 8, 2023
- 2 min read
BMJ 2022;376:o702 http://dx.doi.org/10.1136/bmj.o702 Published: 16 March 2022
The Illusion of Evidence-Based Medicine, exposing the crisis of credibility in clinical research
The open and transparent publication of data are in keeping with our moral obligation to trial participants—real people who have been involved in risky treatment and have a right to expect that the results of their participation will be used in keeping with principles of scientific rigour. Industry concerns about privacy and intellectual property rights should not hold sway.
🔺Women injured by medical devices call for the criminal prosecution of regulators
Particularly for HEALTH & SAFETY Regulators that :
act solely in the interests of industry
put stakeholder interests above patient safety
fail to take proper safety and/or precautionary measures to protect the public from harm
put patients and users at risk of harm, serious injury, chronic life altering pain, suffering or death
🔺 Government run, industry funded, regulators that are immune to scrutiny or prosecution are part of a very serious problem.
Women and children exposed to dangerous devices join calls for a new-style of Medicines and Medical Devices regulator: one that puts it’s Public Duties before stakeholders financial interests and can adhere to the highest safety standards and ethics:
accountability
transparency
independence
impartiality
integrity
honesty
The illusion of evidence based medicine
Evidence based medicine has been corrupted by corporate interests, failed regulation, and commercialisation of academia, argue the authors: Jon Jureidini, Leemon B. McHenry
the bmj | BMJ 2022;376:o702 | doi: 10.1136/bmj.o702 The Illusion of Evidence-Based Medicine, exposing the crisis of credibility in clinical research
The book is available on Amazon
🔺 From FDA to MHRA: are drug regulators for hire?
Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies they are meant to regulate?
From FDA to MHRA: are drug regulators for hire? BMJ2022; 377doi: https://doi.org/10.1136/bmj.o1538(Published 29 June 2022) BMJ 2022;377:o1538
The British Medical Journal investigates
From FDA to MHRA: are drug regulators for hire? BMJ2022; 377doi: https://doi.org/10.1136/bmj.o1538(Published 29 June 2022) BMJ 2022;377:o1538
🔺MEDICAL DEVICES HARM PATIENTS WORLDWIDE AS GOVERNMENTS FAIL ON SAFETY
A global investigation reveals the rising human toll of lax controls and testing standards pushed by a booming industry.
On the 25th November, 2018 the International Consortium of Investigative Journalists raised the red flag 🚩 forcing the FDA to respond.
By February 2023 the European Union’s own lobbyist 🚩 the European Commission, had managed to delay critical medical devices reform and concentrate more power and influence to negligent Notified Bodies.
In the UK, 🚩 the MHRA, with the Government and the Department of Health have been operating a cover-up on the PIP Breast implant and surgical mesh scandals.
A global investigation reveals the rising human toll of lax controls and testing standards pushed by a booming industry. By ICIJ November 25, 2018
Join us for a forthcoming episode of the Global Game of Implants, where we discuss the action or inertia by international regulators approving dangerous medical devices impacting on the health and lives of women and ask: Are Industry funded Health & Safety regulators fit for purpose? And, Does reform really go far enough? Or, Are criminal prosecutions needed to send a clearer message?
Comments